Immunoliposomal form of simvastatin - an attempt to use in the treatment of EGFR-dependent tumors.

2016/21/B/NZ7/01070

Keywords

Descriptors

  • NZ7_14: Farmacja, farmakoterapia, farmakologia
  • NZ5_7: Leczenie chorób człowieka

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Uniwersytet Wrocławski, Wydział Biotechnologii

Voivodeship: dolnośląskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

prof. Aleksander Franciszek Sikorski

Number of co-investigators in the project: 3

Call

OPUS 11 – announced on 2016-03-15

Amount awarded
387 400 PLN
Project start date
2017-01-18
Project end date
2019-04-17
Project duration
27 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (4)

  1. Kierowany za pomocą przeciwciał, liposomowy preparat statyny oraz jego zastosowanie

    Authors:
    Lucyna Matusewicz, Aleksander F. Sikorski
    Academic press:
    Biuletyn Urzędu Patentowego (year: 2019, volume: 23/2019, pages: 6, 425432 udzielony patent Pat.236106), Publisher: URZĄD PATENTOWY RZECZYPOSPOLITEJ POLSKIEJ
    Status:
    Published
  2. Attempts to use statins in cancertherapy: An update

    Authors:
    Lucyna Matusewicz, Aleksander Czogalla and Aleksander F Sikorski
    Academic press:
    Tumor Biology (year: 2020, volume: 42(7), pages: 7), Publisher: SAGE
    Status:
    Published
    DOI:
    10.1177/1010428320941760.2020 – link to the publication
  3. Immunoliposomes with Simvastatin as a Potential Therapeutic in Treatment of Breast Cancer Cells Overexpressing HER2-An In Vitro Study.

    Authors:
    Matusewicz L, Podkalicka J, Sikorski AF.
    Academic press:
    Cancers (Basel). (year: 2018, volume: 10(11)., pages: pii: E418.), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/cancers10110418. – link to the publication
  4. EGFR-targeted immunoliposomes as a selective delivery system of simvastatin, with potential use in treatment of triple-negative breast cancers

    Authors:
    Lucyna Matusewicz1, Beata Filip-Psurska2, Mateusz Psurski2, Sabina Tabaczar1, Joanna Podkalicka1, Joanna Wietrzyk2, Piotr Ziółkowski3, Aleksander Czogalla1, Aleksander F. Sikorski1
    Academic press:
    International Journal of Parmaceutics (year: 2019, volume: 569,, pages: 118605), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ijpharm.2019.118605 – link to the publication

Articles in post-conference publications (2)

  1. Liposomes targeted with Therapeutic Antibodies a Lego-block Versatile Tool for Anticancer Therapy.

    Authors:
    Sikorski A.F.
    Conference:
    PCS 4th Annual Global Cancer Conference-2017 and PCS 4th World Congerss of Cardiothoratic-Renal Diseases-2017, Lisbon, (year: 2017, pages: abstr. P.11), Publisher: PCS
    Date:
    conference 4-5.11
    Status:
    Published
  2. Simvastatin immunoliposomes as potential therapeutic treatment of EGF receptor family-dependent breast tumors.

    Authors:
    Matusewicz L., Sikorski A.F.
    Conference:
    Liposome Advances, Progress in Drug and Vaccine Delivery. ILS and Liposome research Days Combined Conference (year: 2017, pages: 82), Publisher: ILS
    Date:
    conference 16-17. 09
    Status:
    Published

« New search

Graphic design and implementation: Jakub Piotrowski